Magnetic resonance contrast enhancement of latrogenic septal myocardial infarction in hypertrophic cardiomyopathy

被引:18
|
作者
Sievers, B
Moon, JCC
Pennell, DJ
机构
[1] Ruhr Univ Bochum, Marien Hosp, Dept Cardiol & Angiol, Bochum, Germany
[2] Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6LY, England
关键词
D O I
10.1161/hc0802.101576
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1018 / 1018
页数:1
相关论文
共 50 条
  • [31] Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
    Tilman A Hees
    Benjamin Herzog
    Arnt Kristen
    Hugo A Katus
    Hassan Abdel-Aty
    Journal of Cardiovascular Magnetic Resonance, 15 (Suppl 1)
  • [32] Magnetic resonance imaging assessment of the efficacy of septal alcohol ablation for hypertrophic cardiomyopathy
    Kothari, S
    Morice, MC
    Garot, J
    Louvard, Y
    Dumas, P
    Tavolaro, O
    Lévy, M
    Cormier, B
    Malergue, MC
    CIRCULATION, 2004, 110 (17) : 727 - 727
  • [33] Magnetic resonance imaging assessment of the efficacy of septal alcohol ablation for hypertrophic cardiomyopathy
    Kothari, S
    Morice, MC
    Garot, J
    Cormier, B
    Malergue, MC
    Lefèvre, T
    Louvard, Y
    Dumas, P
    EUROPEAN HEART JOURNAL, 2004, 25 : 52 - 52
  • [34] Induced septal infarction nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy
    Kuhn, HJ
    CIRCULATION, 1998, 97 (07) : 708 - 709
  • [35] No delayed enhancement on contrast magnetic resonance imaging with Takotsubo cardiomyopathy
    Teraoka, K
    Kiuchi, S
    Takada, N
    Hirano, M
    Yamashina, A
    CIRCULATION, 2005, 111 (16) : E261 - E262
  • [36] Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent
    Pfeiffer, B.
    Rigopoulos, A.
    Seggewiss, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (41) : 2093 - 2096
  • [37] Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients
    Wang, Chunhua
    Zheng, Jie
    Sun, Jiayu
    Wang, Yuqing
    Xia, Rui
    Yin, Qian
    Chen, Wei
    Xu, Zigian
    Liao, Jichun
    Zhang, Bing
    Gao, Fabao
    JOURNAL OF CARDIOLOGY, 2015, 66 (5-6) : 520 - 526
  • [38] Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    Nagueh, SF
    Lakkis, NM
    He, ZX
    Middleton, KJ
    Killip, D
    Zoghbi, WA
    Quiñones, MA
    Roberts, R
    Verani, MS
    Kleiman, NS
    Spencer, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (01) : 225 - 229
  • [39] MYOCARDIAL MASS QUANTITATION BY MAGNETIC-RESONANCE-IMAGING IN HYPERTROPHIC CARDIOMYOPATHY
    LIU, P
    WILANSKY, S
    POON, P
    HENKELMAN, M
    LEVITT, M
    THOMPSON, R
    WIGLE, ED
    CIRCULATION, 1986, 74 (04) : 226 - 226
  • [40] Progression of myocardial fibrosis in hypertrophic cardiomyopathy: a study with cardiac magnetic resonance
    Todiere, G.
    Pingitore, A.
    Barison, A.
    Masci, P.
    Formisano, F.
    Lombardi, M.
    Aquaro, G. D.
    EUROPEAN HEART JOURNAL, 2011, 32 : 589 - 589